Proceedings of the National Academy of Sciences · 1990 · 21 citations · 20 references
MedicineCell BiologyOncologyCarcinogenesisNeoplasiaTumor ProgressionCancer ProgressionMalignant NeoplasmsMalignant TumorsNeoplastic TransformationOncogene ActivationSquamous Cell CarcinomaDna In Situ HybridizationMalignant ProgressionMechanisms Of Oncogenic ConversionMolecular CarcinogenesisMolecular Mechanisms Of CarcinogenesisNeoplastic Progression
Plasticity of human tumor populations could account for the reason why many tumorigenic human cell lines lose this feature when grown in culture. Methyl methanesulfonate (MMS) was used to convert premalignant squamous cell carcinoma (SCC) cell line SCC-83-01-82 to a malignant phenotype. The MMS-treated SCC-83-01-82 cells (MMS-SCC-83-01-82) produced progressively growing tumors in 5 of 11 splenectomized BALB/c nude mice within 3-5 months. A cell line, designated SCC-83-01-82 CA, was established in vitro from one of the mouse tumors and was repassaged successively. This SCC-83-01-82 CA cell line was aggressively tumorigenic. A tumor greater than or equal to 2.0 cm in size was present within a month, as opposed to the 3-5 months required for the tumors produced by the MMS-SCC-83-01-82 cells. Examination of frozen cross sections by in situ hybridization revealed that focal areas of the tumor produced by the MMS-SCC-83-01-82 cells expressed MYC and HRAS mRNA. However, by the third passage in vivo, the levels of expression of the corresponding genes in the mouse tumors were undetectable. Blot-hybridization analysis of the RNA from the MMS-SCC-83-01-82 cells and the subsequently derived tumors and cells did not indicate any consistent overexpression of MYC, HRAS, or KRAS. Restriction fragment length polymorphism analysis of both MYC and HRAS genes revealed neither rearrangement nor amplification of MYC nor point mutation in the 11th or 12th codon of HRAS. The data suggest that alterations in MYC and HRAS were not directly involved in either the initial transformation or MMS-induced tumorigenic conversion of the SCC-83-01-82 cell line. Persistence of tumorigenicity after reisolation of the MMS-converted premalignant SCC-83-01-82 cells did not disappear immediately following the treatment with MMS.
20
Mechanism of met oncogene activation
Morag Park, Michael Dean, Colin S. Cooper et al. · Cell · 1986 · 558 citations
Point Mutational Inactivation of the Retinoblastoma Antioncogene
Jonathan M. Horowitz, David W. Yandell, Sangho Park et al. · Science · 1989 · 420 citations
Transformation of Human Bronchial Epithelial Cells Transfected by Harvey <i>ras</i> Oncogene
George H. Yoakum, John F. Lechner, Edward Gabrielson et al. · Science · 1985 · 195 citations